Medical Device | March 16, 2023
Biocorp and HRA Pharma to jointly develop a medical device innovation
Biocorp will receive an initial milestone payment this year
Biocorp will receive an initial milestone payment this year
Time to combine innovation, access and technology to deliver positive patient outcomes
The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone
The WHO - Global Center for Traditional Medicine will help member countries in taking enabling steps in their countries for strengthen education and practices of traditional mdicine
Receives Subject Expert Committee recommendation to bring new therapies of Pompe, ASMD to India
First approval for Daiichi Sankyo and AstraZeneca’s ENHERTU in China
The marketing authorisations for three generic drugs signifying advances in cancer treatment will considerably benefit thousands of patients by improving access, ensuring affordability
The company's consolidated revenues for the quarter grew 36% to Rs. 3,020 crore on the back of robust performance across all its three businesses
According to GlobalData’s analyst consensus forecast, OTX-2002 is projected to have the highest revenue by 2028, with sales of $1.6 billion during that year
The Applied Biosystems TaqPath PCR kits have been analytically- and clinically-validated for use in patient care
Subscribe To Our Newsletter & Stay Updated
